1. Home
  2. RAVE vs ATRA Comparison

RAVE vs ATRA Comparison

Compare RAVE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

HOLD

Current Price

$3.07

Market Cap

44.8M

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$8.21

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAVE
ATRA
Founded
1958
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
38.9M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
RAVE
ATRA
Price
$3.07
$8.21
Analyst Decision
Sell
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
23.2K
49.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
122.52
EPS
0.15
N/A
Revenue
$15,120,000.00
$120,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$3.92
52 Week High
$3.75
$19.15

Technical Indicators

Market Signals
Indicator
RAVE
ATRA
Relative Strength Index (RSI) 40.01 41.98
Support Level $3.03 $7.65
Resistance Level $3.13 $9.11
Average True Range (ATR) 0.15 0.64
MACD -0.01 0.07
Stochastic Oscillator 19.53 30.88

Price Performance

Historical Comparison
RAVE
ATRA

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: